Your browser doesn't support javascript.
loading
The effect of the Covid-19 pandemic on illness perceptions of psoriasis and the role of depression: Findings from a cross-sectional study.
Lada, Georgia; Chinoy, Hector; Talbot, Peter S; Warren, Richard B; Kleyn, C Elise.
Afiliação
  • Lada G; Dermatology Centre Salford Royal NHS Foundation Trust Manchester National Institute for Health Research Biomedical Research Centre The University of Manchester Manchester UK.
  • Chinoy H; Division of Neuroscience and Experimental Psychology Faculty of Biology, Medicine and Health The University of Manchester Manchester UK.
  • Talbot PS; National Institute for Health Research Manchester Biomedical Research Centre Manchester University NHS Foundation Trust The University of Manchester Manchester UK.
  • Warren RB; Division of Neuroscience and Experimental Psychology Faculty of Biology, Medicine and Health The University of Manchester Manchester UK.
  • Kleyn CE; Dermatology Centre Salford Royal NHS Foundation Trust Manchester National Institute for Health Research Biomedical Research Centre The University of Manchester Manchester UK.
Skin Health Dis ; 2(3): e145, 2022 Sep.
Article em En | MEDLINE | ID: mdl-36092261
Background: Illness perceptions in psoriasis have an impact on adherence and disability. Changes in dermatological healthcare provision during the Covid-19 pandemic and distress may have affected illness perceptions in psoriasis patients. Objectives: To test whether illness perceptions about psoriasis changed during the first year of the Covid-19 pandemic compared to pre-pandemic in a tertiary population with psoriasis and whether pandemic effects differed depending on depressive burden, given this population's high depression prevalence. Methods: In a cross-sectional survey of n = 188 tertiary patients with dermatologist-confirmed psoriasis recruited before and during the pandemic, eight illness perceptions domains were assessed using the Brief-Illness Perceptions Questionnaire (BIPQ). Presence of depression was assessed with the Hospital Anxiety and Depression Scale (HADS). Results: Beliefs about treatment control and patients' understanding of psoriasis were significantly worse in patients responding during the pandemic compared to before Covid-19. These differences were greater when depression was absent (treatment control: adjusted p < 0.001; coherence: adjusted p = 0.01). However, participants during the pandemic felt less emotionally affected (adjusted p = 0.02) and concerned (adjusted p = 0.007) about psoriasis, independently of depression. Conclusions: We found diverse pandemic effects on illness perception domains in psoriasis. Uncertainty and reduced healthcare access may drive poorer treatment and coherence beliefs during Covid-19. These beliefs can hinder patients' health-promoting behaviours and may explain the high pandemic non-adherence reported previously in psoriasis. Appropriate interventions are needed to establish positive long-term cognitions and improve psoriasis management, for example, using the PsoWell patient materials. Dermatology services should invest in engaging and educating patients regardless of concurrent psychological distress.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Skin Health Dis Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Skin Health Dis Ano de publicação: 2022 Tipo de documento: Article